Associations of HLA-C alleles with multinodular goiters: Study in a population from Southeastern Spain

Archives of Surgery

Volumn 141, Issue 2, 2006, Pages 123-128

  Ríos, Antonio ^a,b   Rodríguez, Jose M ^a   Moya, María R ^a   Galindo, Pedro J ^a   Canteras, Manuel ^a   Alvarez, María R ^a   Parrilla, Pascual ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HLA C ANTIGEN;

ADULT; ALLELE; ARTICLE; CARCINOMA; CLINICAL FEATURE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; NODULAR GOITER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSTERNAL GOITER; RISK FACTOR; SURGICAL TECHNIQUE; THYROID CARCINOMA; THYROID DISEASE;

ALLELES; DNA; FEMALE; GENE FREQUENCY; GENOTYPE; GOITER, NODULAR; HLA-C ANTIGENS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN;

EID: 33244496921     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.141.2.123     Document Type: Article

References (52)

1. Hurley DL, Gharib H. Evaluation and management of multinodular goiter. Otolaryngol Clin North Am. 1996;29:527-540.
2. Aguayo J, Sakatsume Y, Jamieson C, Row VV, Volpe R. Nontoxic nodular goiter and papillary thyroid carcinoma are not associated with peripheral blood lymphocyte sensitization to thyroid cells. J Clin Endocrinol Metab. 1989;68:145-149.
3. Jansson R, Karlsson A, Forsum V. Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goiter. Clin Exp Immunol. 1984;58:264-272.
4. Van der Gaag RD, Drexhage HA, Wiersinga WM, et al. Further studies on thyroid growth stimulating immunoglobulins in euthyroid nonendemic goiter. J Clin Endocrinol Metab. 1985;60:972-979.
5. Kabel PJ, Voorbij HA, De Haan M, van der Gaag RD, Drexhage HA. Intrathyroidal dendritic cells. J Clin Endocrinol Metab. 1988;66:199-207.
6. Kraiem Z, Glaser B, Yigla M, Pauker J, Sadeh O, Sheinfeld M. Toxic multinodular goiter: a variant of autoimmune hyperthyroidism. J Clin Endocrinol Metab. 1987;65:659-664.
7. Corrales JJ, Orfao A, Miralles JM, et al. Immunological features of sporadic multinodular goiter. Clin Investig. 1993;71:552-558.
8. Grubeck-Loebenstein B, Derfler K, Kassal H, et al. Immunological features of non-immunogenic hyperthyroidism. J Clin Endocrinol Metab. 1985;60:150-155.
9. Wall JR, Baur R, Schleusener H, Bandy P. Peripheral blood and intrathyroidal mononuclear cell populations in patients with autoimmune thyroid disorders enumerated using monoclonal antibodies. J Clin Endocrinol Metab. 1983;56:164-169.
10. Rigopoulou D, Martínez J, Martínez F, et al. Both class I and class II HLA antigens are thyroid cancer susceptibility factors. Tissue Antigens. 1994;43:281-285.
11. Ahuja S, Hoppe I, von Keyserlingk H, Ernst H. HLA and thyroid carcinoma. Exp Clin Endocrinol. 1992;99:134-136.
12. Bunce M, Welsh KI. Rapid DNA typing for HLA-C using sequence specific primers (PCR-SSP): identification of serological and non-serologically defined HLA-C alleles including several new alleles. Tissue Antigens. 1994;43:7-17.
13. Bunce M, Barnardo MCNM, Welsh KI. Improvements in HLA-C typing using sequence-specific primers (PCR-SSP) including definition of HLA-Cw9 and Cw10 and a new allele HLA-"Cw7/8v." Tissue Antigens. 1994;44:200-203.
14. Levine JE, Yang SY. SSOP typing of the Tenth International Histocompatibility Workshop reference cell lines for HLA-C alleles. Tissue Antigens. 1994;44:174-183.
15. Ando H, Mizuki N, Ando R, et al. HLA-C genotyping in the Japanese population by the PCR-SSP method. Tissue Antigens. 1996;48:55-58.
16. Dahan M, Gaillard J, Eschapase H. Surgical treatment of goiters with intrathoracic development. In: Delarue NC, Eschapase H, eds. Thoracic Surgery: Frontiers and Uncommon Neoplasms: International Trends in General Thoracic Surgery. St Louis, Mo: Mosby; 1989:5-10.
17. Svejgaard A, Ryder LP. HLA and disease associations: detecting the strongest association. Tissue Antigens. 1994;43:18-27.
18. Geelhoed GW. Tracheomalacia from compressing goiter: management after thyroidectomy. Surgery. 1988;104:1100-1108.
19. Takahata N. MHC diversity and selection. Immunol Rev. 1995;143:225-247.
20. DeGroot LJ, Quintans J. The causes of autoimmune thyroid disease. Endocr Rev. 1989;10:537-562.
21. Duquesnoy RJ. Immunogenetics of the human major histocompatibility complex. Clin Lab Med. 1991;11:509-536.
22. Heward J, Gough SC. Genetic susceptibility to the development of autoimmune disease. Clin Sci (Lond). 1997;93:479-491.
23. Weetman AP. New aspects of thyroid immunity. Horm Res. 1997;48(suppl 4):51-54.
24. Thorsby E. Invited anniversary review: HLA associated disease. Hum Immunol. 1997;53:1-11.
25. McLachlan SM. The genetic basis of autoimmune thyroid disease: time to focus on chromosomal loci other than the major histocompatibility complex (HLA in man). J Clin Endocrinol Metab. 1993;77:605A-605C.
26. Dalton TA, Bennett JC. Autoimmune disease and the major histocompatibility complex: therapeutic implications. Am J Med. 1992;92:183-188.
27. Kotsa K, Watson F, Weetman APA. CTLA-4 gene polymorphism is associated with both Graves' disease and autoimmune hypothyroidism. Clin Endocrinol (Oxf). 1997;46:551-554.
28. Farid NR. Are the immune responses to endocrine autoantigens genetically restricted? Autoimmunity. 1989;3:47-55.
29. Tamai H, Kimura A, Dong RP, et al. Resistance to autoimmune thyroid disease is associated with HLA-DQ. J Clin Endocrinol Metab. 1994;78:94-97.
30. Yanagawa T, Mangklabruks A, DeGroot LJ. Strong association between HLA-DQA1*0501 and Graves' disease in a male Caucasian population. J Clin Endocrinol Metab. 1994;79:227-229.
31. Cho BY, Chung JH, Shong YK, et al. A strong association between thyrothopin receptor-blocking antibody-positive atrophic autoimmune thyroiditis and HLA-DR8 and HLA-DQB1*0302 in Koreans. J Clin Endocrinol Metab. 1993;77:611-615.
32. Honda K, Tamai H, Morita T, Kuma K, Nishimura Y, Sasazuki T. Hashimoto's thyroiditis and HLA in Japanese. J Clin Endocrinol Metab. 1989;69:1268-1273.
33. Maenpaa J, Lautenschlager I, Nyberg M, Koskimies S, Kontiaimen S. Thyroid infiltrating lymphocytes, thyroid function, and HLA-DR in juvenile autoimmune thyroiditis. Acta Endocrinol (Copenh). 1989;121:573-577.
34. Parkes AB, Darke C, Othman S, et al. Major histocompatibility complex class II and complement polymorphisms in postpartum thyroiditis. Eur J Endocrinol. 1996;134:449-453.
35. Bogner U, Badenhoop K, Peters H, et al. HLA-DR/DQ gene variation in nongoitrous autoimmune thyroiditis at the serological and molecular level. Autoimmunity. 1992;14:155-158.
36. Rasovskii BL, Dimova MN, Kiseleva TP, Akhmed'ianova LG, Minina VM. Antigens of the HLA system in nodular formations of the thyroid gland [in Russian]. Probl Endokrinol (Mosk). 1993;39:28-30.
37. Papasteriades C, Alevizaki MN, Economidou J, Ikkos DG. HLA antigens in Greek patients with thyrotoxicosis (Graves' disease and toxic nodular goiter). J Endocrinol Invest. 1984;7:283-286.
38. Ozaki O, Ito K, Kobayashi K, Suzuku A, Manabe Y, Hosoda Y. Familial occurrence of differentiated, nonmedullary thyroid carcinoma. World J Surg. 1988;12:565-571.
39. Koyama S, Mitsuishi Y, Bibee K, Watanabe I, Terasaki PI. HLA associations with Meniere's disease. Acta Otolaryngol. 1993;113:575-578.
40. Ivanyi P, Ivanyi D, Zemek P. HLA Cw4 in paranoid schizophrenia. Tissue Antigens. 1977;9:41-44.
41. Wakitani S, Imoto K, Mazuka T, Kim S, Murata N, Yoneda M. Japanese generalised osteoarthritis was associated with HLA class I: a study of HLA-A, B, Cw, DR in 72 patients. Clin Rheumatol. 2001;20:417-419.
42. Bortin MM, D'Amaro J, Bach FH, Rimm AA, van Rood JJ. HLA associations with leukemia. Blood. 1987;70:227-232.
43. Grundschober C, Labonne MP, Javaux F, Steiner QG, Gebuhrer L, Tiercy JM. Sequence of four new HLA-Cw alleles: a possible role of interallelic recombination. Tissue Antigens. 1998;51:72-79.
44. Sanz L, González F, de Pablo R, Nuñez Roldan A, Kreisler M, Vilches C. HLACw*1602: a new susceptibility marker of Behçet's disease in southern Spain. Tissue Antigens. 1998;51:111-114.
45. Hendel H, Caillat-Zucman S, Lebuanec H, et al. New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. J Immunol. 1999;162:6942-6946.
46. Carrel S, Schreyer M, Spagnoli G, Cerottini JC, Rimoldi D. Monoclonal antibodies against recombinant-MAGE-1 protein identify a cross-reacting 72-kDa antigen which is co-expressed with MAGE-1 protein in melanoma cells. Int J Cancer. 1996;67:417-422.
47. van der Bruggen P, Szikora JP, Boel P, et al. Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601. Eur J Immunol. 1994;24:2134-2140.
48. Araki K, Noguchi Y, Hirouchi T, et al. Cancer regression induced by modified CTL therapy is regulated by HLA class II and class I antigens in Japanese patients with advanced cancer. Int J Oncol. 2000;17:1107-1118.
49. Heidecker L, Brasseur F, Probst-Kepper M, Gueguen M, Boon T, Van den Eynde BJ. Cytolytic T lymphocytes raised against a human bladder carcinoma recognize an antigen encoded by gene MAGE-A12. J Immunol. 2000;164:6041-6045.
50. Ríos A, Rodríguez JM, Illana J, Torregrosa NM, Parrilla P. Familial papillary carcinoma of the thyroid: report of 3 families. Eur J Surg. 2001;167:339-343.
51. From G, Mellemgaard A, Knudsen N, Jorgensen T, Perrild H. Review of thyroid cancer cases among patients with previous benign thyroid disorders. Thyroid. 2000;10:697-700.
52. Ríos A, Rodríguez JM, Moya MR, et al. Frequency of HLA-C alleles in differentiated thyroid carcinoma in southeastern Spain: HLA-Cw7 as a poor prognosis factor. Cancer. 2004;100:264-269.